In recent years, Artificial Intelligence (AI) has made significant strides across various sectors, providing innovative solutions and enhancing efficiency. However, ...

Insiders at the Food and Drug Administration are ringing alarm bells over the agency's use of an AI to fast-track drug ...

FDA Commissioner Marty Makary recently hinted at the use of AI in drug reviews, saying the agency had just completed its first AI-assisted review. (Via: Wired) ...

The Food and Drug Administration just announced that it will immediately start using AI across all of its centers, after completing a new generative AI pilot for scientific reviewers.. Supposedly ...

Following the lead of other federal agencies, the FDA has announced a plan to incorporate AI soon. It could speed up drug approvals, but it's controversial.

It looks like there’s no limit to the uses for AI, with the US Drug and Food Administration (FDA) announcing that it plans to use the technology to approve drug and medical devices faster in the ...

FDA officials want to leverage AI for drug and device approval, animal testing, and data processing, as the Trump administrations slashes its workforce.

FDA’s Broader AI Goals. The launch of Elsa is part of a broader “AI-forward” strategy. In January 2025, the agency issued a draft guidance on considerations for the use of AI to support ...

On May 8, 2025, the Food and Drug Administration (FDA) announced the completion of its generative artificial intelligence (AI) pilot program for scientific reviewers. 1 FDA Commissioner Marty ...

The FDA may be facing a 4% cut to its overall budget courtesy of the Trump administration, but that hasn’t stopped the agency from unveiling a new generative AI tool a month ahead of schedule ...

The U.S. Food and Drug Administration said on Thursday all its centers will deploy artificial intelligence internally immediately, with full integration on June 30, following the completion of a ...